TESNOR
Natural health product licensed in Canada
- Licence holder
- Barentz Canada ULC
- NPN or DIN-HM
- 80128428
- Status
- Active licence
- Licence date
- 6 December 2023
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Theobroma cacao Source : Theobroma cacao - Graine Potency : 6.66 % Theobromine | 60 mg | Not calculated |
| Punica granatum Potency : 10.8 % Punicalagin | 240 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Silice, Maltodextrine, Hypromellose, Phosphate dicalcique, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Hommes | minimum: 21 years ; maximum: 55 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support an increase in hand grip strength. Clinically proven to help promote/support free testosterone levels (in men). Clinically proven to help promote/support testosterone production (in men). Clinically proven to help promote an increase in free testosterone in men (within the normal range). Clinically proven to help promote healthy testosterone production in males. Supports positive effects on perceived stress in men with symptoms of androgen decline. Helps to reduce symptoms of perceived stress in men with symptoms of androgen decline. Helps to relieve symptoms of perceived stress in men with symptoms of androgen decline.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80128428
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.